Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Jul-22 4:05 PM View:  | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 29-Jun-22 | Market Purchase | 20,000 | $1.71 | $34,200.00 | 258% 7.75K to 27.75K | (4%) |
| 28-Mar-22 8:00 AM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 25-Mar-22 | Private Purchase | 100,000 | $0.25 | $24,500.00 | 68% 148.02K to 248.02K | |
| 28-Sep-21 5:04 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 28-Sep-21 | Private Purchase | 12,000 | $0.61 | $7,320.00 | 9% 136.02K to 148.02K | |
| 11-Feb-22 10:00 PM View: | Saenger Bradley Chief Financial Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 30-Jun-21 | Grant | 18,248 | $0.58 | $10,583.80 | 1306% 1.4K to 19.64K | |
| 11-Feb-22 10:00 PM View: | Sullivan Gregory M Chief Medical Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 30-Jun-21 | Grant | 36,496 | $0.58 | $21,167.70 | 58% 62.73K to 99.22K | |
| 26-May-21 9:07 AM View: | Goodman Daniel Wintner Director | Tonix Pharmaceuticals Holdi... (TNXP) | 25-May-21 | Private Purchase | 5,000 | $1.12 | $5,600.00 | 500000% 1 to 5.0K | |
| 25-Mar-21 7:00 AM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 24-Mar-21 | Private Purchase | 16,733 | $1.32 | $22,087.60 | 14% 119.29K to 136.02K | |
| 25-Feb-21 5:47 PM View: | Sullivan Gregory M Chief Medical Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 07-Jan-21 | Grant | 41,322 | $0.51 | $21,074.20 | 193% 21.41K to 62.73K | |
| 04-Jan-21 5:01 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 30-Dec-20 | Private Purchase | 35,000 | $0.68 | $23,800.00 | 42% 83.83K to 118.83K | |
| 01-Sep-20 9:03 AM View: | Treco James Director | Tonix Pharmaceuticals Holdi... (TNXP) | 31-Aug-20 | Private Purchase | 5,500 | $0.89 | $4,895.00 | 122% 4.5K to 10.0K | |
| 24-Aug-20 9:00 AM View: | Bell Margaret Smith Director | Tonix Pharmaceuticals Holdi... (TNXP) | 20-Aug-20 | Private Purchase | 5,391 | $0.93 | $4,997.46 | 100% 0 to 5.39K | |
| 19-Aug-20 9:02 AM View: | Sullivan Gregory M Chief Medical Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 17-Aug-20 | Private Purchase | 20,000 | $1.03 | $20,600.00 | 1423% 1.41K to 21.41K | |
| 17-Aug-20 9:06 AM View: | Treco James Director | Tonix Pharmaceuticals Holdi... (TNXP) | 14-Aug-20 | Private Purchase | 4,500 | $1.06 | $4,770.00 | 100% 0 to 4.5K | |
| 17-Aug-20 9:03 AM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 13-Aug-20 | Private Purchase | 60,000 | $0.91 | $54,600.00 | 247% 24.29K to 84.29K | |
| 17-Aug-20 9:04 AM View: | Olukotun Adeoye Y Director | Tonix Pharmaceuticals Holdi... (TNXP) | 13-Aug-20 | Private Purchase | 5,350 | $0.94 | $5,029.00 | 100% 0 to 5.35K | |
| 17-Aug-20 9:00 AM View: | Bagger Richard H Director | Tonix Pharmaceuticals Holdi... (TNXP) | 13-Aug-20 | Private Purchase | 10,000 | $0.91 | $9,100.00 | 100% 0 to 10.0K | |
| 12-Feb-21 10:00 PM View: | Saenger Bradley Chief Financial Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 06-Jan-20 | Grant | 493 | $1.02 | $502.86 | 55% 0.9K to 1.4K | |
| 04-Dec-19 7:00 AM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 03-Dec-19 | Private Purchase | 20,000 | $1.16 | $23,180.00 | 466% 4.29K to 24.29K | |
| 14-Feb-20 10:00 PM View: | Saenger Bradley Chief Financial Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 31-Jul-19 | Grant | 815 | $11.82 | $9,633.30 | 916% 89 to 0.9K | |
| 14-Feb-20 10:00 PM View: | Sullivan Gregory M Chief Medical Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 31-Jul-19 | Grant | 1,142 | $11.82 | $13,498.40 | 434% 0.26K to 1.41K | |
| 01-Apr-19 8:22 AM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 29-Mar-19 | Market Purchase | 5,000 | $2.49 | $12,440.00 | 13% 37.88K to 42.88K | (3%) |
| 28-Mar-19 5:13 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 26-Mar-19 | Market Purchase | 25,000 | $2.38 | $59,375.00 | 194% 12.88K to 37.88K | 9% |
| 14-Feb-20 10:00 PM View: | Saenger Bradley Chief Financial Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 17-Feb-19 | Grant | 59 | $17.85 | $1,053.15 | 7% 0.84K to 0.9K | |
| 14-Feb-20 10:00 PM View: | Sullivan Gregory M Chief Medical Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 17-Feb-19 | Grant | 59 | $17.85 | $1,053.15 | 4% 1.35K to 1.41K | |
| 02-Jul-18 4:30 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 29-Jun-18 | Market Purchase | 500 | $4.64 | $2,320.00 | < 1% 124.31K to 124.81K | (96%) |
| 29-Jun-18 4:30 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 28-Jun-18 | Market Purchase | 500 | $4.58 | $2,290.00 | < 1% 123.81K to 124.31K | (96%) |
| 28-Jun-18 4:30 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 27-Jun-18 | Market Purchase | 500 | $4.55 | $2,275.00 | < 1% 123.31K to 123.81K | (96%) |
| 27-Jun-18 4:30 PM View: | Mario Ernest Director | Tonix Pharmaceuticals Holdi... (TNXP) | 25-Jun-18 | Market Purchase | 16,500 | $4.48 | $73,920.00 | 49% 33.5K to 50.0K | (96%) |
| 15-Jun-18 7:05 AM View: | Sullivan Gregory M Chief Medical Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 14-Jun-18 | Market Purchase | 10,000 | $3.96 | $39,650.00 | 95% 10.48K to 20.48K | (95%) |
| 14-Jun-18 4:05 PM View: | Saenger Bradley Chief Financial Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 14-Jun-18 | Market Purchase | 300 | $4.10 | $1,230.00 | 11% 2.78K to 3.08K | (95%) |
| 14-Jun-18 4:05 PM View: | Morris Jessica Edgar Chief Operating Officer | Tonix Pharmaceuticals Holdi... (TNXP) | 14-Jun-18 | Market Purchase | 300 | $4.19 | $1,257.00 | 22% 1.34K to 1.64K | (95%) |
| 14-Jun-18 4:06 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 12-Jun-18 | Market Purchase | 1,000 | $4.37 | $4,370.00 | < 1% 117.39K to 118.39K | (96%) |
| 14-Jun-18 4:06 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 12-Jun-18 | Market Purchase | 2,000 | $4.37 | $8,740.00 | 2% 118.39K to 120.39K | (96%) |
| 06-Jun-18 4:05 PM View: | Rhodes John B Director | Tonix Pharmaceuticals Holdi... (TNXP) | 01-Jun-18 | Market Purchase | 7,500 | $3.33 | $24,975.00 | 47% 15.97K to 23.47K | (94%) |
| 30-May-18 10:00 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 25-May-18 | Market Purchase | 4,000 | $3.17 | $12,680.00 | 4% 110.48K to 114.48K | (94%) |
| 28-Feb-18 10:00 PM View: | Mather Charles E Iv Director | Tonix Pharmaceuticals Holdi... (TNXP) | 27-Feb-18 | Option Exercise | 750 | -- | -- | 6% 11.83K to 12.58K | |
| 09-Mar-18 3:32 PM View: | Mario Ernest Director | Tonix Pharmaceuticals Holdi... (TNXP) | 09-Feb-18 | Gift | 10,000 | -- | -- | 30% 33.5K to 43.5K | |
| 09-Mar-18 3:32 PM View: | Mario Ernest Director | Tonix Pharmaceuticals Holdi... (TNXP) | 09-Feb-18 | Gift | 10,000 | -- | -- | (23%) 43.5K to 33.5K | |
| 27-Dec-17 2:04 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 26-Dec-17 | Market Purchase | 5,300 | $3.61 | $19,133.00 | 5% 111.01K to 116.31K | (95%) |
| 22-Dec-17 4:58 PM View: | Mario Ernest Director | Tonix Pharmaceuticals Holdi... (TNXP) | 21-Dec-17 | Market Sale | 5,000 | $3.46 | $17,300.00 | (13%) 38.5K to 33.5K | 94% |
| 22-Dec-17 4:58 PM View: | Mario Ernest Director | Tonix Pharmaceuticals Holdi... (TNXP) | 20-Dec-17 | Market Sale | 8,965 | $3.44 | $30,839.60 | (19%) 47.47K to 38.5K | 94% |
| 22-Dec-17 4:58 PM View: | Mario Ernest Director | Tonix Pharmaceuticals Holdi... (TNXP) | 19-Dec-17 | Market Sale | 6,035 | $3.51 | $21,182.80 | (11%) 53.5K to 47.47K | 95% |
| 22-Dec-17 4:58 PM View: | Mario Ernest Director | Tonix Pharmaceuticals Holdi... (TNXP) | 18-Dec-17 | Market Sale | 10,000 | $3.57 | $35,700.00 | (16%) 63.5K to 53.5K | 95% |
| 22-Dec-17 4:58 PM View: | Mario Ernest Director | Tonix Pharmaceuticals Holdi... (TNXP) | 15-Dec-17 | Market Sale | 5,000 | $3.55 | $17,750.00 | (7%) 68.5K to 63.5K | 95% |
| 22-Dec-17 4:58 PM View: | Mario Ernest Director | Tonix Pharmaceuticals Holdi... (TNXP) | 14-Dec-17 | Market Sale | 1,967 | $3.58 | $7,041.86 | (3%) 67.43K to 65.47K | 95% |
| 18-Aug-17 3:40 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 17-Aug-17 | Market Purchase | 15,000 | $3.00 | $45,067.50 | 16% 93.09K to 108.09K | (94%) |
| 18-Aug-17 3:40 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 16-Aug-17 | Market Purchase | 5,000 | $2.99 | $14,950.00 | 6% 88.09K to 93.09K | (94%) |
| 30-Jun-17 5:38 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 30-Jun-17 | Market Purchase | 5,000 | $4.33 | $21,640.00 | 6% 79.84K to 84.84K | (96%) |
| 30-Jun-17 8:55 PM View: | Mario Ernest Director | Tonix Pharmaceuticals Holdi... (TNXP) | 30-Jun-17 | Market Sale | 6,105 | $4.28 | $26,117.20 | (8%) 75.07K to 68.97K | 96% |
| 26-Jun-17 5:29 PM View: | Lederman Seth Chief Executive Officer Director | Tonix Pharmaceuticals Holdi... (TNXP) | 26-Jun-17 | Market Purchase | 5,000 | $4.40 | $21,999.50 | 7% 71.92K to 76.92K | (96%) |
